Clinical Trial Update: A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose [Phase 1]

View source ↗

Summary

A Phase 1 study to assess the safety and reactogenicity of an investigational pneumococcal vaccine given as a single booster to toddlers aged 12 to 15 months. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Investigational pneumococcal vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pneumonia, Bacterial | Phase 1 | Status: NOT_YET_RECRUITING